MedTrace Logo

The Impact of a Polyphenol-Rich Supplement on Epigenetic and Cellular Markers of Immune Age

NCT05234203 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-12-06

No results posted yet for this study

Summary

This is a prospective, interventional, single-arm, open-label pilot study of 50 patients to evaluate the effect of a polyphenol-rich nutritional supplement on epigenetic and cellular markers of immune age.

Conditions

Interventions

DIETARY_SUPPLEMENT

HTB Rejuvenate

90 days of BID dosing of 2 capsules of HTB Rejuvenate

Sponsors & Collaborators

  • TruDiagnostic

    collaborator INDUSTRY

  • Big Bold Health, PBC

    lead INDUSTRY

Principal Investigators

  • Jeffrey S Bland, Ph.D · Big Bold Health

  • Austin D Perlmutter, MD · Big Bold Health

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-25
Primary Completion
2022-10-07
Completion
2022-10-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05234203 on ClinicalTrials.gov